Concord, CA, United States of America

Keith R McCrea

This inventor holds 23 USPTO granted patents and 7 published patent applications and 3 EPO patents, primarily in Blood Filtration Technology. Top assignees: Exthera Medical Corporation, Dsm IP Assets B.v., Biomimedica, Inc.. Active years: 2010-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Keith R McCrea. Retrieved from https://idiyas.com/inventor/keith-r-mccrea

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 23 

% Patents Active = 82.6

 

Average Co-Inventor Count = 3.0

ph-index = 10

Forward Citations = 212(Granted Patents)


Company Filing History:


Years Active: 2010-2024

Loading Chart...
Loading Chart...
Areas of Expertise:
Blood Filtration
Cytokine Removal
Infectious Disease Diagnostics
Endothelial Glycocalyx
Wearable Hemoperfusion
Surface Modification
Polyurethane-grafted Hydrogels
High Flow Rate
Drug Intoxication Treatment
Blood-borne Pathogens
Polysaccharides
Amphipathic Endgroups
23 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Keith R. McCrea

Introduction

Keith R. McCrea is a prominent inventor based in Concord, CA, with a remarkable portfolio of 23 patents. His contributions to the field of medical technology demonstrate a profound commitment to developing methods and devices aimed at enhancing patient care.

Latest Patents

Among his latest innovations, McCrea has developed a method for modulating endothelial glycocalyx structure. This innovative approach provides methods and devices for augmenting impaired glycocalyx barrier function by using a glycocalyx-mimetic adsorption media. This media contains glycosaminoglycan structures and optionally, proteoglycan core proteins, aimed at enhancing and restoring glycocalyx barrier function. The procedure allows for the treatment of patients by infusing a treated sample back into the subject.

Additionally, McCrea has patented a method for treating drug intoxication. This invention describes methods and devices for cleansing a contaminated sample from a subject by utilizing specially selected adsorption media that possess antithrombogenic properties. This method facilitates the separation of drug targets from the sample, producing a cleansed sample that can be reinfused, offering a significant advancement in treating drug intoxication.

Career Highlights

Throughout his career, Keith R. McCrea has worked with various organizations, notably Exthera Medical Corporation and Dsm IP Assets B.V. His innovative spirit has propelled advancements in the medical field, particularly in developing technologies that address critical health challenges.

Collaborations

Collaboration has been a cornerstone of McCrea's work, as evidenced by his partnerships with notable coworkers such as Robert S. Ward and Olle Larm. These collaborations have further enriched his research and development efforts, leading to significant innovations in medical treatments.

Conclusion

Keith R. McCrea's dedication to innovation has undoubtedly made a lasting impact in the medical technology sector. His work not only exemplifies ingenuity but also highlights the continuous pursuit of better solutions for patient care. With a substantial number of patents to his name, McCrea remains a significant figure in the realm of medical inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…